{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:52:39Z","timestamp":1791049959802,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2019.00092","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T05:07:19Z","timestamp":1562908039000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":74,"title":["CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief Review of the Literature"],"prefix":"10.3389","volume":"6","author":[{"given":"Giannis G.","family":"Baltogiannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios N.","family":"Lysitsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"di Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ciconte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theofilos M.","family":"Kolettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian-Battista","family":"Chierchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"de Asmundis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Brugada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"B1","first-page":"28","article-title":"Catecholamine induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases","volume":"40","author":"Coumel","year":"1978","journal-title":"Br Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachy- cardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.yjmcc.2008.10.012","article-title":"Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice","volume":"46","author":"Liu","year":"2009","journal-title":"J Molec Cell Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1161\/CIRCULATIONAHA.116.021936","article-title":"Constitutive Intracellular Na+ excess in purkinje cells promotes arrhythmogenesis at lower levels of stress than ventricular myocytes from mice with catecholaminergic polymorphic ventricular tachycardia","volume":"133","author":"Willis","year":"2016","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/CIRCRESAHA.108.171660","article-title":"Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model","volume":"103","author":"Rizzi","year":"2008","journal-title":"Circ Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.joa.2015.09.008","article-title":"Current topics in catecholaminergic polymorphic ventricular tachycardia","volume":"32","author":"Sumitomo","year":"2016","journal-title":"J Arrhythm."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3390\/biology6010007","article-title":"Cardiac channelopathies and sudden death: recent clinical and genetic advances","volume":"6","author":"Fern\u00e1ndez-Falgueras","year":"2017","journal-title":"Biology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1172\/JCI25664","article-title":"Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels","volume":"115","author":"Priori","year":"2005","journal-title":"J Clin Investig"},{"key":"B9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/jmg.2004.028993","article-title":"Catecholaminergic polymorphic ventricular tachycardia: Ryr2 mutations, bradycardia, and follow up of the patients","volume":"42","author":"Postma","year":"2005","journal-title":"J Med Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1536\/ihj.47.381","article-title":"Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT)","volume":"47","author":"Aizawa","year":"2006","journal-title":"Int Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/anec.12191","article-title":"Utility of the exercise electrocardiogram testing in sudden cardiac death risk stratification","volume":"19","author":"Refaat","year":"2014","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"B12","article-title":"Catecholaminergic polymorphic ventricular tachycardia","volume-title":"Gene Reviews","author":"Napolitano","year":"1993"},{"key":"B13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pcad.2007.10.005","article-title":"Catecholaminergic polymorphic ventricular tachycardia","volume":"51","author":"Liu","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.hrthm.2013.07.021","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"15","author":"Priori","year":"2013","journal-title":"Europace"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","article-title":"Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator","volume":"71","author":"Chatzidou","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ven- tricular arrhythmias in patients with catechol- aminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0735\u20131097(02)01946\u20130","article-title":"Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers","volume":"40","author":"Bauce","year":"2002","journal-title":"J Am Coll Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/heart.89.1.66","article-title":"Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death","volume":"89","author":"Sumitomo","year":"2003","journal-title":"Heart"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1161\/01.CIR.103.23.2822","article-title":"Autosomal recessive catecholamine- or exerciseinduced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13\u201321","volume":"103","author":"Lahat","year":"2001","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/S0735\u20131097(99)00461\u20131","article-title":"Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts","volume":"34","author":"Swan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/europace\/eup448","article-title":"High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members","volume":"12","author":"Haugaa","year":"2010","journal-title":"Europace"},{"key":"B22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/cvr\/cvm058","article-title":"Dynamic interactions of an intracellular Ca2+ clock and membrane ion channel clock underlie robust initiation and regulation of cardiac pacemaker function","volume":"77","author":"Maltsev","year":"2008","journal-title":"Cardiovasc Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.hrthm.2012.12.035","article-title":"Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia","volume":"10","author":"Watanabe","year":"2013","journal-title":"Heart Rhythm."},{"key":"B24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.yjmcc.2009.10.005","article-title":"Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass","volume":"48","author":"Hilliard","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical control trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12471\u2013014-0523\u20132","article-title":"Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes","author":"Olde Nordkamp","year":"2014","journal-title":"Neth Heart J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtcvs.2013.07.064","article-title":"Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias","volume":"147","author":"Hofferberth","year":"2014","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1161\/CIRCRESAHA.111.247338","article-title":"Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity","volume":"109","author":"Liu","year":"2011","journal-title":"Circ Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jacbts.2016.04.004","article-title":"Neuronal Na+ Channels Are Integral Components of Pro-arrhythmic Na+\/Ca2+ Signaling Nanodomain That Promotes Cardiac Arrhythmias During \u03b2-adrenergic Stimulation","volume":"1","author":"Radwanski","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"B31","first-page":"27","article-title":"Treatment of catecholaminergic polymorphic ventricular tachycardia: lessons from one case","volume":"9","author":"Sioros","year":"2014","journal-title":"Hospital Chron."},{"key":"B32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jacc.2014.12.031","article-title":"Implantable Cardioverter-defibrillator therapy in Brugada Syndrome: a 20 year single center experience","volume":"65","author":"Conte","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.hrthm.2017.03.025","article-title":"Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models","volume":"14","author":"Kurtzwald-Josefson","year":"2017","journal-title":"Heart Rhythm."},{"key":"B34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/HCO.0000000000000360","article-title":"Catecholaminergic polymorphic ventricular tachycardia: a model for genotype-specific therapy","volume":"32","author":"Roston","year":"2017","journal-title":"Curr Opin Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2019.00092\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T10:11:59Z","timestamp":1563185519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2019.00092\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":34,"alternative-id":["10.3389\/fcvm.2019.00092"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2019.00092","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"article-number":"92"}}